BMS CA 209-331-001 An Open label, Randomized Phase 3 Study of Nivolumab or Chemo
Clinical Trial Grant
Awarded By
The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership
Start Date
July 1, 2015
End Date
June 30, 2022
Awarded By
The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership
Start Date
July 1, 2015
End Date
June 30, 2022